Clinical Trial Update: NIT-OCCLUD PDA Phase II Sentinel Trial [NA]

View source ↗

Summary

A Phase II sentinel trial evaluating the NIT-OCCLUD PDA device for closing patent ductus arteriosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• NIT-OCCLUD PDA

Snippet

Sponsor: PFM Medical, Inc | Conditions: Ductus Arteriosus, Patent | NA | Status: COMPLETED